Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 49,499 | 27,792 | 31,188 | 31,293 | 18,264 |
| Operating Income | -49,499 | -27,792 | -31,188 | -31,293 | -18,264 |
| Other Income | 1,787 | 1,610 | 1,907 | 2,469 | 2,765 |
| Pre-tax Income | -47,712 | -26,182 | -29,281 | -28,824 | -15,499 |
| Net Income Continuous | -47,712 | -26,182 | -29,281 | -28,824 | -15,499 |
| Net Income | $-47,712 | $-26,182 | $-29,281 | $-28,824 | $-15,499 |
| EPS Basic Total Ops | -0.61 | -0.41 | -0.46 | -0.47 | -0.24 |
| EPS Basic Continuous Ops | -0.61 | -0.41 | -0.46 | -0.46 | -0.24 |
| EPS Diluted Total Ops | -0.61 | -0.41 | -0.46 | -0.47 | -0.24 |
| EPS Diluted Continuous Ops | -0.61 | -0.41 | -0.46 | -0.46 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 |
| EBITDA(a) | $-49,736 | $-28,166 | $-31,855 | $-32,398 | $-19,903 |